PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States.\', \'Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: Baolin.zhang@fda.hhs.gov.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1368-7646(20)30063-710.1016/j.drup.2020.100733
?:hasPublicationType
?:journal
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33161277
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 update: The race to therapeutic development.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all